tirzepatide weight loss medicine How the drug is also helping heart failure patients FDA approves new version of

People with obesity and related health problems have to pay 130 ($142.33) for the same amount

Neuropsychiatric safety should be a key consideration in any clinical riskbenefit assessment associated with GLP1 anti-obesity medications and the analysis provided here contribute to thoughtful and objective decision-making and dialogue between patients and clinicians

For residents of Fort Mill, SC, these benefits represent not just a step toward their weight loss goals but also toward a healthier, more vibrant life

A series of state and federal lawsuits challenging coverage exclusions for obesity drugs and procedures are testing the bounds of what qualifies as a disability under discrimination laws as more workers seek to access the expensive treatments

Case Study 2: Managing Co-Occurring Medical and ED Needs Client Profile: A 25-year-old female presenting with OSFED, Major Depressive Disorder, and Generalized Anxiety Disorder, admitted to PHP to manage mood, anxiety, and ED symptoms